J Korean Ophthalmol Soc.  2015 Oct;56(10):1650-1650. 10.3341/jkos.2015.56.10.1650.

Letter to the Editor: Effect of Intravitreal Bevacizumab Injection on Retinopathy of Prematurity

• Kim YC

• KMID: 2214430
• DOI: http://doi.org/10.3341/jkos.2015.56.10.1650

Abstract

No abstract available.

MeSH Terms

Retinopathy of Prematurity*
Bevacizumab

Reference

References

1. Kim SE, Rim TH, Lee CS. Effect of primary intravitreal bev-acizumab injection on stage 3 retinopathy of prematurity with plus signs. J Korean Ophthalmol Soc. 2015; 56:62–9.

2. Beer PM, Wong SJ, Hammad AM. . Vitreous levels of unbound bevacizumab and unbound vascular endothelial growth factor in two patients. Retina. 2006; 26:871–6.

3. Harder BC, von Baltz S, Jonas JB, Schlichtenbrede FC. Intravitreal bevacizumab for retinopathy of prematurity. J Ocul Pharmacol Ther. 2011; 27:623–7.